The Nobel Prize for Medicine has again been awarded jointly, this time for miRNA discovery and its role in gene regulation

The Alliance for RTU has been founded to accelerate and improve manufacturing quality, consistency, and regulatory efficiency.

Here’s a look at recent violations cited in FDA Warning Letters: fly pupae, cross contamination, trial dosing errors, and more.

Michael Altorfer, CEO, Swiss Biotech Association, gives his view on the future of drug development.

Why the traditional model of drug development is no longer fit for purpose.

We asked over 100 industry professionals for their views on the future of the pharma and biopharma industries.

Sitting Down With… Lars Petersen, President and CEO, FUJIFILM Diosynth Biotechnologies

Continuous processing for small molecule products has been a hot topic for years, but where does the industry stand with it today?

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.

A look back at some of the most inspiring quotes from our interviews.